Products - National Blood Authority | National Blood Authority

In a letter dated 16 December 2014, the FDA approved Cerus’ Intercept Blood System for plasma. This system is used by blood establishments in the preparation of plasma in order to reduce the risk of transfusion-transmitted infections (TTI), including HIV, hepatitis B and C and West Nile Virus. ................
................